These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5360796)

  • 21. [Glucose fatty acid cycle in diabetes mellitus].
    Shima K; Tarui S
    Saishin Igaku; 1969 Mar; 24(3):527-33. PubMed ID: 4890887
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic effects of chronic caffeine administration in a patient with diabetes mellitus.
    Alberti KG; Hockaday TD; Williamson DH
    Proc R Soc Med; 1972 May; 65(5):485-6. PubMed ID: 5083686
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of subcutaneous insulin infusions on the metabolic regulation in unstable diabetics].
    Keller U; Viollier E; Schwarz U; Girard J; Berger W
    Schweiz Med Wochenschr; 1980 Nov; 110(47):1754-60. PubMed ID: 7006075
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes of plasma free fatty acids associated with diabetes treated by glyconormal: 30 clinical cases].
    Warembourg H; Jaillard J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():431-4. PubMed ID: 5377003
    [No Abstract]   [Full Text] [Related]  

  • 25. [Significance of nonesterified fatty acids in the diagnosis of early forms of diabetes mellitus].
    Sviatelik GV
    Vrach Delo; 1980 May; (5):9-11. PubMed ID: 6994352
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipid metabolic indices in diabetes mellitus].
    Potemkin VV
    Sov Med; 1980; (4):108-10. PubMed ID: 7384868
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of physical exercise on the glyco-lipid effect in normal and diabetic subjects].
    Ferlito S; Di Mauro C; Costa A; Branca S; Raudino M
    G Clin Med; 1980 Oct; 61(10):728-39. PubMed ID: 7016646
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged].
    Locatelli GR; Piotti LE
    G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.
    Vega GL; Cater NB; Meguro S; Grundy SM
    Am J Cardiol; 2005 Jun; 95(11):1309-13. PubMed ID: 15904634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis of the brittle type of diabetes mellitus].
    Fujita R
    Rinsho Byori; 1968 Jun; 16(6):494-7. PubMed ID: 5749535
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of sulfonylureas on lipid levels in diabetic patients].
    Sgambato S; Cristiano L; Torella R
    Rass Int Clin Ter; 1968 Apr; 48(8):455-62. PubMed ID: 5736035
    [No Abstract]   [Full Text] [Related]  

  • 33. [Plasma levels of triglycerides, cholesterol, non-esterified fatty acids and uric acid, during oral glucose load, in subjects with type II diabetes and diminished glucose tolerance].
    Sinagra D; Botta RM; Lo Curzio E; Cerasola GA
    Boll Soc Ital Biol Sper; 1982 Aug; 58(15):964-70. PubMed ID: 6751356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Response of the peripheral venous free fatty acids to insulin administered by the peripheral venous route in normal and diabetic subjects].
    Bostanci N
    Turk Tip Cemiy Mecm; 1970; 36(3):176-81. PubMed ID: 5501880
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postheparin increase of free fatty acids in healthy subjects and in some pathological states].
    Fabian E; Stork A; Kucerová L; Sponarová J
    Cas Lek Cesk; 1967 Dec; 106(50):1348-50. PubMed ID: 5594465
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of the concentration of serum free fatty acids in type 2 diabetic].
    Yi B; Li XJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):212-4. PubMed ID: 16145918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On several pathogenetic aspects of diabetes of diabetes mellitus in the aged patient. Case contribution].
    De Lorenzi F; Isola G
    Arch Maragliano Patol Clin; 1967; 23(6):677-98. PubMed ID: 5633209
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].
    Gragnoli G; Pupillo A; Montagnani M; Bayeli PF
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1373-90. PubMed ID: 5759915
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development, after oral dose of carbutamide in diabetics, of plasma levels of glucose, insulin, free fatty acids and sulfonamide].
    Mantel O; Fiet J; Dreux C; Canivet J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():293-300. PubMed ID: 5376987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.